Ariadne Genomics Inc. type 2 diabetes mellitus repaglinide nateglinide repaglinide pharmacokinetics pathway nateglinide pharmacokinetics pathway nateglinide ---> potassium channel inhibitors pharmacodynamics pathway repaglinide ---> repaglinide pharmacokinetics pathway nateglinide ---> nateglinide pharmacokinetics pathway repaglinide ---> potassium channel inhibitors pharmacodynamics pathway insulin secretion pathway potassium channel inhibitors pharmacodynamics pathway --+> insulin secretion pathway potassium channel inhibitors pharmacodynamics pathway potassium channel inhibitors pharmacodynamics pathway ---| type 2 diabetes mellitus pathway potassium channel inhibitors pharmacodynamics pathway ---| type 2 diabetes mellitus type 2 diabetes mellitus pathway